Met Proto-Oncogene and Insulin-Like Growth Factor Binding Protein 3 Overexpression Correlates With Metastatic Ability in Well-Differentiated Pancreatic Endocrine Neoplasms

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-04-0285
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

C-Met Proto-Oncogene (MET; HGFR); Hepatocyte Growth Factor/Scatter Factor (HGF/SF)

Science-Business eXchange
2014English

Variation in Plasma Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3: Genetic Factors

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2005English

Insulin-Like Growth Factor-Binding Protein

2020English

Gene Expression Patterns of Insulin-Like Growth Factor 1, Insulin-Like Growth Factor 2 and Insulin-Like Growth Factor Binding Protein 3 in Human Placenta From Pregnancies With Intrauterine Growth Restriction

Journal of Perinatal Medicine
GynecologyChild HealthPediatricsPerinatologyObstetrics
2011English

Circulating Insulin-Like Growth Factor Binding Protein-1 and the Risk of Pancreatic Cancer

Cancer Research
Cancer ResearchOncology
2007English

Insulin-Like Growth Factor I and Insulin-Like Growth Factor Binding Protein 3 as Determinants of Blood Hemoglobin Concentration in Healthy Subjects

Pediatric Research
Child HealthPediatricsPerinatology
1994English

Role of Insulin-Like Growth Factor Binding Protein-3 in Glucose and Lipid Metabolism

Annals of Pediatric Endocrinology and Metabolism
Child HealthEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2013English

Tumorigenicity of the Met Proto-Oncogene and the Gene for Hepatocyte Growth Factor.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1992English

Insulin Receptor Substrate-2 Mediated Insulin-Like Growth Factor-I Receptor Overexpression in Pancreatic Adenocarcinoma Through Protein Kinase C

Cancer Research
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy